Sign in

CIK 0001678660

  • Non-accelerated filer
  • Smaller reporting company

Prelude Therapeutics Inc

Sign in to watch
Ticker
PRLD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
811384762
Phone
+1 302-467-1280
Business address
175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
Former names
Prelude Therapeutics Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2026-02-04 Scherle Peggy Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +230,000 230,000
2025-02-04 Scherle Peggy Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +175,000 175,000
2024-03-01 Scherle Peggy Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +150,000 150,000
2023-02-07 Scherle Peggy Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +135,000 135,000
2022-02-15 Scherle Peggy Chief Scientific Officer Grant or award · Employee Stock Option (right to buy) +100,000 100,000
2021-08-27 Scherle Peggy Chief Scientific Officer Exercise or conversion +6,014 $1.43 $9K 178,934
2021-08-27 Scherle Peggy Chief Scientific Officer Sale −2,700 $35.32 $95K 176,234
2021-08-27 Scherle Peggy Chief Scientific Officer Sale −2,707 $36.23 $98K 173,527
2021-08-27 Scherle Peggy Chief Scientific Officer Sale −607 $37.08 $23K 172,920
2021-08-27 Scherle Peggy Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) −6,014 27,018
2021-08-26 Scherle Peggy Chief Scientific Officer Exercise or conversion +1,700 $1.43 $2K 174,620
2021-08-26 Scherle Peggy Chief Scientific Officer Sale −1,700 $35.19 $60K 172,920
2021-08-26 Scherle Peggy Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) −1,700 33,032
2021-08-13 Scherle Peggy Chief Scientific Officer Exercise or conversion +558 $1.89 $1K 173,478
2021-08-13 Scherle Peggy Chief Scientific Officer Exercise or conversion +1,728 $1.43 $2K 175,206
2021-08-13 Scherle Peggy Chief Scientific Officer Sale −2,286 $35.07 $80K 172,920
2021-08-13 Scherle Peggy Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) −558 42,672
2021-08-13 Scherle Peggy Chief Scientific Officer Exercise or conversion · Employee Stock Option (Right to Buy) −1,728 34,732
2021-07-27 Scherle Peggy Chief Scientific Officer Exercise or conversion +20,000 $1.43 $29K 192,920
2021-07-27 Scherle Peggy Chief Scientific Officer Sale −19,320 $35.45 $685K 173,600

Page 1 of 2 · 39 trades